Ovarian cancer (OC) represents one of the most letal cancers in women. The aim of surgical
treatment consists of complete cytoreduction in advanced stages and a surgical staging in …

The ovarian cancer recurrence occurs in 75% of patients with advanced FIGO stage, and its
treatment is a challenge for the oncologist in gynecology. The standard treatment of …

Objective Retrospective series have shown minimally invasive secondary cytoreductive
surgery is a feasible approach in selected cases of recurrent ovarian cancer. However, no …

Abstract Study Objective To analyze the feasibility and safety of laparoscopic secondary
cytoreductive surgery in a retrospective series of patients with platinum-sensitive recurrent …

Background We aimed to investigate the therapeutic efficacy and safety of Pressurized
IntraPeritoneal Aerosol Chemotherapy (PIPAC) in platinum-resistant recurrence of ovarian …

Objective Accumulating evidence support that complete cytoreduction (CC) at the time of
secondary cytoreductive surgery (SCS) improves survival in patients affected by recurrent …

Background to assess the feasibility of minimally invasive surgery in the management of
lymph-nodal recurrences of gynecological cancers, in terms of surgical and oncological …

Objective This study is aimed to analyze the clinical outcome of recurrent ovarian cancer
patients bearing isolated lymph-node recurrence (ILNR) who underwent salvage …

The objective of the present review is to thoroughly investigate the role of minimally invasive
surgery (MIS) in the setting of secondary cytoreduction for ovarian cancer recurrence …

Introduction Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy
(CRS/HIPEC) is an established treatment for pseudomyxoma peritonei (PMP) from …